UK Markets closed

Novozymes A/S (NVZMY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
70.26+1.63 (+2.38%)
At close: 3:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close68.62
BidN/A x N/A
AskN/A x N/A
Day's range69.11 - 70.45
52-week range54.55 - 81.35
Avg. volume7,983
Market cap39.249B
Beta (5Y monthly)0.27
PE ratio (TTM)42.55
Earnings dateN/A
Forward dividend & yield0.84 (1.10%)
Ex-dividend date12 Mar 2021
1y target estN/A
  • Globe Newswire

    Novozymes is unlocking growth with the ambition of doubling company revenue by 2030

    With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with the ambition to double the company’s revenue by 2030. COPENHAGEN, DENMARK – 27 September 2021 – “Unlocking Growth – Powered by Biotech” is Novozymes’ strategy towards 2025 based on the solid foundation and successful execution of “Better Business with Biology”. As part of ‘Unlocking Growth’ Novozymes

  • Globe Newswire

    Novozymes announces its 2025 strategy: Unlocking growth – powered by biotech

    Please read the full announcement in PDF Attachment 2021_46_Novozymes_announces_ 2025_strategy

  • Globe Newswire

    Novozymes is combining cutting-edge science and business expertise to help feed the world sustainably

    To feed a growing population, Novozymes is inviting all interested parties to help co-create and innovate the future of sustainable protein. By combining science with business expertise Novozymes wants to rethink how protein is made and sourced by enabling a new and progressive industry to provide sustainable nutrition. COPENHAGEN, DENMARK – 21 September, 2021 – As the U.N. Food System Summit sets the stage to bring about tangible, positive changes to the world’s food systems, Novozymes, the wor